| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |